Immediate Impact

4 standout
Sub-graph 1 of 2

Citing Papers

Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update
2023 Standout
Targeted therapeutic options and future perspectives for HER2-positive breast cancer
2019 Standout
2 intermediate papers

Works of Sekhar Marla being referenced

Poor survival outcomes in HER2 positive breast cancer patients with low grade, node negative tumours. Implications for trastuzumab therapy?.
2009
Systematic review of day surgery for breast cancer
2009

Author Peers

Author Last Decade Papers Cites
Sekhar Marla 160 77 83 21 224
Francesca Catalano 100 47 59 18 223
Sara Holden 178 96 44 20 269
Almir José Sarri 93 72 122 20 236
Lisa Whisker 163 82 34 35 220
Marilot C. T. Batenburg 136 57 174 19 278
Ammar Asban 184 65 45 28 278
R. S. Murley 116 41 34 28 236
Erin Duralde 134 20 38 18 288
Patricia Fairbrother 61 57 63 27 159
Andrea Tilley 138 37 228 13 299

All Works

Loading papers...

Rankless by CCL
2026